Page last updated: 2024-08-23

androstane-3,17-diol and Atypical Endometrial Hyperplasia

androstane-3,17-diol has been researched along with Atypical Endometrial Hyperplasia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gratterola, R1

Other Studies

1 other study(ies) available for androstane-3,17-diol and Atypical Endometrial Hyperplasia

ArticleYear
Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast.
    Cancer research, 1978, Volume: 38, Issue:9

    Topics: Adult; Androstane-3,17-diol; Androstanes; Anovulation; Breast Diseases; Breast Neoplasms; Cysts; Endometrial Hyperplasia; Female; Humans; Luteal Phase; Middle Aged; Risk; Testosterone

1978